{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:43:23Z","timestamp":1786574603329,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbagen.2024.130732","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T16:29:01Z","timestamp":1733156941000},"page":"130732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["BMY 7378, a selective \u03b11D-adrenoceptor antagonist, is a new angiotensin converting enzyme inhibitor: In silico, in vitro and in vivo approach"],"prefix":"10.1016","volume":"1869","author":[{"given":"Jessica E.","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Andrade-Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Barquet-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Estrada-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzell A.","family":"Gallardo-Ort\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Villalobos-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2024.130732_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","article-title":"Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy","volume":"50","author":"Bader","year":"2010","journal-title":"Rev. Adv. Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1016\/j.bbagen.2024.130732_bb0010","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.bbagen.2024.130732_bb0015","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S1357-2725(02)00273-X","article-title":"Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact?","volume":"35","author":"Tom","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbagen.2024.130732_bb0020","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1139\/cjpp-2016-0619","article-title":"Kallikrein-kinin system as the dominant mechanism to counteract hyperactive renin-angiotensin system","volume":"95","author":"Regoli","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"40","key":"10.1016\/j.bbagen.2024.130732_bb0025","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/hr.2017.65","article-title":"Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?","volume":"4011","author":"Nehme","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/0014-2999(94)00751-R","article-title":"BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors","volume":"272","author":"Goetz","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbagen.2024.130732_bb0035","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1021\/jm030944+","article-title":"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor","volume":"47","author":"Leonardi","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0040","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bioorg.2018.02.022","article-title":"Potent ACE inhibitors from 5-hydroxy indanone derivatives","volume":"77","author":"Vulupala","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.arcmed.2004.11.009","article-title":"The hypotensive effect of BMY 7378 involves central 5-HT1A receptor stimulation in the adult but not in the young rat","volume":"35","author":"Villalobos-Molina","year":"2004","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1474-8673.2005.00342.x","article-title":"The \u03b1 1D -adrenoceptor antagonist BMY 7378 is also an \u03b1 2C -adrenoceptor antagonist","volume":"25","author":"Cleary","year":"2005","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.bbagen.2024.130732_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/aap.12035","article-title":"Role of \u03b11D -adrenoceptors in vascular wall hypertrophy during angiotensin II-induced hypertension","volume":"35","author":"Gallardo-Ort\u00edz","year":"2015","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.bbagen.2024.130732_bb0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0188-4409(03)00076-6","article-title":"Early and chronic captopril or losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats","volume":"34","author":"Mart\u00ednez","year":"2003","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1474-8673.2005.00358.x","article-title":"Captopril therapy decreases both expression and function of alpha-adrenoceptors in pre- hypertensive rat aorta","volume":"26","author":"God\u00ednez-Hern\u00e1ndez","year":"2006","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.bbagen.2024.130732_bb0070","series-title":"Son-ne, Gaussian 09, Revision A 1; Gaussian","author":"Frisch","year":"2009"},{"issue":"421","key":"10.1016\/j.bbagen.2024.130732_bb0075","first-page":"551","article-title":"Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex","volume":"4216922","author":"Natesh","year":"2003","journal-title":"Nat. 2003"},{"key":"10.1016\/j.bbagen.2024.130732_bb0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/1873-3468.14768","article-title":"Structural insights into the inhibitory mechanism of angiotensin-I-converting enzyme by the lactotripeptides IPP and VPP","volume":"598","author":"Gregory","year":"2024","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbagen.2024.130732_bb0085","first-page":"7735","article-title":"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as \u03b11A\/1D-AR subselective antagonists for BPH, bioorganic","volume":"23","author":"Xu","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0090","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0095","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0003-2697(78)90053-2","article-title":"A rapid and simple spectrophotometric assay of angiotensin-converting enzyme","volume":"84","author":"Hayakari","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.phymed.2004.07.002","article-title":"Validation of a colorimetric assay for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE) from plant extracts","volume":"12","author":"Serra","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbagen.2024.130732_bb0110","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00044-021-02707-8","article-title":"Phthalamide derivatives as ACE\/AChE\/BuChE inhibitors against cardiac hypertrophy: an in silico, in vitro, and in vivo modeling approach","volume":"30","author":"Andrade-Jorge","year":"2021","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0115","first-page":"1293","article-title":"Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays","volume":"301","author":"Pedersen","year":"2011","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.bbagen.2024.130732_bb0120","doi-asserted-by":"crossref","first-page":"13982","DOI":"10.1021\/acs.jafc.0c05064","article-title":"Quercetin and its metabolites inhibit recombinant human angiotensin-converting enzyme 2 (ACE2) activity","volume":"68","author":"Liu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.omtn.2017.04.006","article-title":"Translation of angiotensin-converting enzyme 2 upon liver- and lung-targeted delivery of optimized chemically modified mRNA","volume":"7","author":"Schrom","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.bbagen.2024.130732_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.arcmed.2004.11.009","article-title":"The hypotensive effect of BMY 7378 involves central 5-HT1A receptor stimulation in the adult but not in the young rat","volume":"35","author":"Villalobos-Molina","year":"2004","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0135","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1016\/j.bmc.2015.11.020","article-title":"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as \u03b11A\/1D-AR subselective antagonists for BPH","volume":"23","author":"Xu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00044-019-02327-3","article-title":"Novel phthalamide derivatives as antihypertensive agents: rapid and clean synthesis, in silico and in vivo evaluation","volume":"28","author":"Andrade-Jorge","year":"2019","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25020295","article-title":"Considerations for docking of selective angiotensin-converting enzyme inhibitors","volume":"25","author":"Caballero","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2024.130732_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102212","article-title":"Insights into the interactions between maleimide derivates and GSK3\u03b2 combining molecular docking and QSAR","volume":"9","author":"Quesada-Romero","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2024.130732_bb0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/ijerph16060923","article-title":"A molecular docking approach to evaluate the pharmacological properties of natural and synthetic treatment candidates for use against hypertension","volume":"16","author":"Attique","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.bbagen.2024.130732_bb0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1474-8673.2008.00418.x","article-title":"Vascular alpha-1D-adrenoceptors are overexpressed in aorta of the aryl hydrocarbon receptor null mouse: role of increased angiotensin II","volume":"28","author":"Villalobos-Molina","year":"2008","journal-title":"Auton. Autacoid Pharmacol."},{"key":"10.1016\/j.bbagen.2024.130732_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128867","article-title":"Purification and identification of novel ACE inhibitory and ACE2 upregulating peptides from spent hen muscle proteins","volume":"345","author":"Fan","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.12659\/MSMBR.901964","article-title":"Comparative analysis of renin-angiotensin system (RAS)-related gene expression between hypertensive and normotensive rats","volume":"23","author":"Williamson","year":"2017","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0175","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/s41440-019-0297-4","article-title":"Prehypertension exercise training attenuates hypertension and cardiac hypertrophy accompanied by temporal changes in the levels of angiotensin II and angiotensin (1-7)","volume":"42","author":"Peng","year":"2019","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.33549\/physiolres.930024","article-title":"Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats","volume":"50","author":"Jurkovicov\u00e1","year":"2001","journal-title":"Physiol. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0185","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.acthis.2014.08.006","article-title":"Cardiac and renal distribution of ACE and ACE-2 in rats with heart failure","volume":"116","author":"Cohen-Segev","year":"2014","journal-title":"Acta Histochem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0190","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.111.182428","article-title":"Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications","volume":"59","author":"Lee","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.bbagen.2024.130732_bb0195","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/HYPERTENSIONAHA.109.144600","article-title":"Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function","volume":"55","author":"Erd\u00f6s","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.bbagen.2024.130732_bb0200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.RES.0000107195.13573.E4","article-title":"Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells","volume":"94","author":"Kohlstedt","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0205","article-title":"Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin","volume":"294","author":"Marcic","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbagen.2024.130732_bb0210","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/01.HYP.0000150159.48992.11","article-title":"Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells","volume":"vol. 45","author":"Kohlstedt","year":"2005","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"key":"10.1016\/j.bbagen.2024.130732_bb0215","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1080\/10408398.2020.1781049","article-title":"The ACE2\/Ang (1-7)\/MasR axis as an emerging target for antihypertensive peptides","volume":"61","author":"Liao","year":"2021","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bbagen.2024.130732_bb0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.fitote.2009.08.012","article-title":"Puqienine E: An angiotensin converting enzyme inhibitory steroidal alkaloid from Fritillaria puqiensis","volume":"81","author":"An","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bbagen.2024.130732_bb0225","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1021\/jf900494d","article-title":"Plant food-derived angiotensin I converting enzyme inhibitory peptides","volume":"57","author":"Guang","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0230","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.bmcl.2010.01.113","article-title":"The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives","volume":"20","author":"Bonesi","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2024.130732_bb0235","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/jf903515f","article-title":"Flavonoids from the buds of rosa damascena inhibit the activity of 3-Hydroxy-3-methylglutaryl-coenzyme a reductase and angiotensin I-converting enzyme","volume":"58","author":"Kwon","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbagen.2024.130732_bb0240","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00044-013-0895-7","article-title":"Synthesis of 1-benzhydryl piperazine derivatives and evaluation of their ACE inhibition and antimicrobial activities","volume":"23","author":"Santhoshi","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bbagen.2024.130732_bb0245","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bioorg.2018.02.022","article-title":"Potent ACE inhibitors from 5-hydroxy indanone derivatives","volume":"77","author":"Vulupala","year":"2018","journal-title":"Bioorg. Chem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416524001752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416524001752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T09:53:30Z","timestamp":1734429210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416524001752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0304416524001752"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2024.130732","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BMY 7378, a selective \u03b11D-adrenoceptor antagonist, is a new angiotensin converting enzyme inhibitor: In silico, in vitro and in vivo approach","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2024.130732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130732"}}